A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorderWilliam B. White, Michael C. Snabes, Scott Berry et al.|American Heart Journal|2011Cited by 67